Single-domain amnestic mild cognitive impairment identified by cluster analysis predicts Alzheimer's disease in the european prospective DESCRIPA study

Dementia and Geriatric Cognitive Disorders

Volumn 36, Issue 1-2, 2013, Pages 1-19

  Damian, Marinella ^a   Hausner, Lucrezia ^a   Jekel, Katrin ^a   Richter, Melany ^a   Froelich, Lutz ^a   Almkvist, Ove ^d   Boada, Merce ^h   Bullock, Roger ⁱ   De Deyn, Peter Paul ^l   Frisoni, Giovanni B ^m   Hampel, Harald ^b,c   Jones, Roy W ^j   Kehoe, Patrick ^k   Lenoir, Hermine ^o   Minthon, Lennart ^g   Olde Rikkert, Marcel G M ^r   Rodriguez, Guido ⁿ   Scheltens, Philip ^s   Soininen, Hilkka ^u   Spiru, Luiza ^v   Touchon, Jacques ^p   Tsolaki, Magda ^w   Vellas, Bruno ^q   Verhey, Frans R J ^t   Winblad, Bengt ^e   Wahlund, Lars Olof ^f   Wilcock, Gordon ^k   Visser, Pieter Jelle ^s   more..

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c GOETHE UNIVERSITY   (Germany)

^d STOCKHOLM UNIVERSITY   (Sweden)

^e KAROLINSKA INSTITUTE   (Sweden)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^g LUND UNIVERSITY   (Sweden)

^h Fundacio ACE   (Spain)

ⁱ Kingshill Research Centre   (United Kingdom)

^j Research Institute for the Care of Older People (RICE)   (United Kingdom)

^k UNIVERSITY OF BRISTOL   (United Kingdom)

^l UNIVERSITY OF ANTWERP   (Belgium)

^m IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

ⁿ UNIVERSITY OF GENOA   (Italy)

^o Paris Descartes University   (France)

^p INSERM   (France)

^q TOULOUSE UNIVERSITY HOSPITAL   (France)

^r RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^s VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^t MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^u UNIVERSITY OF EASTERN FINLAND   (Finland)

^v CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^w ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

more..

Author keywords

Alzheimer's disease; Conversion to Alzheimer's disease; Mild cognitive impairment; Mild cognitive impairment subtypes

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E4; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; CEREBROSPINAL FLUID ANALYSIS; CLUSTER ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HIERARCHICAL CLUSTER ANALYSIS; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECALL; SENSITIVITY AND SPECIFICITY; TASK PERFORMANCE; TEMPORAL LOBE; VERBAL BEHAVIOR; VERBAL FLUENCY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS E; BIOLOGICAL MARKERS; CLUSTER ANALYSIS; COHORT STUDIES; DISEASE PROGRESSION; EUROPE; FEMALE; GENOTYPE; HUMANS; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MENTAL RECALL; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84877654156     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000348354     Document Type: Article

References (47)

1. Petersen RC, Roberts RO, Knopman DS, Boeve BF, Geda YE, Ivnik RJ, Smith GE, Jack CR Jr: Mild cognitive impairment: ten years later. Arch Neurol 2009; 66: 1447-1455.
2. Nordlund A, Rolstad S, Klang O, Edman A, Hansen S, Wallin A: Two-year outcome of MCI subtypes and aetiologies in the Goteborg MCI study. J Neurol Neurosurg Psychiatry 2010; 81: 541-546.
3. Forlenza OV, Diniz BS, Nunes PV, Memória CM, Yassuda MS, Gattaz WF: Diagnostic transitions in mild cognitive impairment subtypes. Int Psychogeriatr 2009; 21: 1088-1095.
4. Petersen RC: Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 256: 183-194.
5. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, et al: Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004; 256: 240-246.
6. Kochan N, Slavin M, Brodaty H, Crawford JD, Trollor JN, Draper B, Sachdev PS: Effect of different impairment criteria on prevalence of 'objective' mild cognitive impairment in a community sample. Am J Geriatr Psychiatry 2010; 18: 711-722.
7. Jak AJ, Bondi MW, Delano-Wood L, Wierenga C, Corey-Bloom J, Salmon DP, Delis DC: Quantification of five neuropsychological approaches to defining mild cognitive impairment. Am J Geriatr Psychiatry 2009; 17: 368-375.
8. Visser P, Verhey FJ: Mild cognitive impairment as predictor for Alzheimer's disease in clinical practice: effect of age and diagnostic criteria. Psychol Med 2008; 38: 113-122.
9. Levy R: Aging-associated cognitive decline. Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization. Int Psychogeriatr 1994; 6: 63-68.
10. Crook T, Bartus RT, Ferris SH, Whitehouse P, Cohen GD, Gershon S: Age-associated memory impairment. Proposed diagnostic criteria and measures of clinical change: report of a National Institute of Mental Health Work Group. Dev Neuropsychol 1986; 2: 261-276.
11. Reisberg B, Ferris SH, De Leon MJ, Crook T: The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982; 139: 1136-1139.
12. Dubois B, Albert ML: Amnestic MCI or prodromal Alzheimer's disease? Lancet Neurol 2004, 3: 246-248.
13. Levey A, Lah J, Goldstein F, Steenland K, Bliwise D: Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease. Clin Ther 2006; 28: 991-1001.
14. Visser PJ, Verhey FRJ, Boada M, Bullock R, De Deyn PP, Frisoni GB, et al: development of screening guidelines and clinical criteria for predementia Alzheimer's disease. Neuroepidemiology 2008; 30: 254-265.
15. Jessen F, Wiese B, Bachmann C, Eifflaender-Gorfer S, Haller F, Kölsch H, Bickel, H, et al: Prediction of dementia by subjective memory impairment. Arch Gen Psychiatry 2010; 67: 414-422.
16. Reid L, MacLullich AM: Subjective memory complaints and cognitive impairment in older people. Dement Geriatr Cogn Disord 2006; 22: 471-485.
17. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994.
18. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984; 34: 939-944.
19. Visser PJ, Verhey F, Knol DL, Scheltens P, Wahlund L-O, Freund-Levi Y, et al: Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study. Lancet Neurol 2009; 8: 619-627.
20. Van der Elst W, van Boxtel MP, van Breukelen GJ, Jolles J: Rey's verbal learning test: normative data for 1855 healthy participants aged 24-81 years and the influence of age, sex, education, and mode of presentation. J Int Neuropsychol Soc 2005; 11: 290-302.
21. Welsh KA, Butters N, Mohs RC, Beekly D, Edland S, Fillenbaum G, Heyman A: The consortium to establish a registry for Alzheimer's disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology 1994; 44: 609-614.
22. Van der Elst W, Van Boxtel MP, Van Breukelen GJ, Jolles J: Normative data for the animal, profession and letter naming verbal fluency tests for Dutch-speaking participants and the effects of age, education, and sex. J Int Neuropsychol Soc 2006; 12: 80-89.
23. Reitan RM: Trail Making Test: Manual for Administration, Scoring and Interpretation. Indianapolis, Indiana University Press, 1956.
24. Rey A: L'examen psychologique dans les cas d'encephalopathie traumatique. Arch Psychol 1941; 28: 286-340.
25. Folstein MF, Folstein SE, McHugh PR: 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
26. Nobili F, Frisoni GB, Portet F, Verhey F, Rodriguez G, Caroli A, Touchon J, Calvini P, Morbelli S, De Carli F, Guerra UP, Van de Pol LA, Visser PJ: Brain SPECT in subtypes of mild cognitive impairment. Findings from the DESCRIPA multicenter study. J Neurol 2008; 255: 1344-1353.
27. Van de Pol LA, Verhey F, Frisoni GB, Tsolaki M, Papapostolou P, Nobili F, et al: White matter hyperintensities and medial temporal lobe atrophy in clinical subtypes of mild cognitive impairment: the DESCRIPA study. J Neurol Neurosurg Psychiatry 2009; 80: 1069-1074.
28. Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjögren M, Wallin A, Ader H, Leys D, Pantoni L, Pasquier F, Erkinjuntti T, Scheltens P: A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 2001; 32: 1318-1322.
29. Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, Kuiper M, Steinling M, Wolters EC, Valk J: Atrophy of medial temporal lobes on MRI in 'probable' Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992; 55: 967-972.
30. Bergs S: Optimalität bei Cluster-Analysen. Experimente zur Bewertung numerischer Klassifikationsverfahren; dissertation, Universität Münster, 1981.
31. Crum RM, Anthony JC, Bassett SS, Folstein MF: Population-based norms for the mini-mental state examination by age and educational level. JAMA 1993; 18: 2386-2391.
32. Welsh KA, Butters N, Hughes JP, Mohs RC, Heyman A: Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease. Arch Neurol 1992; 49: 448-452.
33. Tabert MH, Manly JJ, Liu X, Pelton GH, Rosenblum S, Jacobs M, Zamora D, Goodkind M, Bell K, Stern Y, Devanand DP: Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch Gen Psychiatry 2006; 63: 916-924.
34. Twamley EW, Ropacki SA, Bondi MW: Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease. J Int Neuropsychol Soc 2006; 12: 707-735.
35. Palmer K, Bäckman L, Winblad B, Fratiglioni L: Mild cognitive impairment in the general population: occurrence and progression to Alzheimer disease. Am J Geriatr Psychiatry 2008; 16: 603-611.
36. Tabert MH, Manly JJ, Liu X, Pelton GH, Rosenblum S, Jacobs M, et al: Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch Gen Psychiatry 2006; 63: 916-924.
37. Ritchie K, Artero S, Touchon J: Classification criteria for mild cognitive impairment. Neurology 2001; 56: 37-42.
38. Ritchie LJ, Tuokko H: Patterns of cognitive decline, conversion rates, and predictive validity for 3 models of MCI. Am J Alzheimers Dis Other Demen 2010; 25: 592-603.
39. Matthews FE, Stephan BC, McKeith IG, Bond J, Brayne C: Two-year progression from mild cognitive impairment to dementia: to what extent do different definitions agree? J Am Geriatr Soc 2008; 56: 1424-1433.
40. Nordlund A, Rolstad S, Göthlin M, Edman A, Hansen S, Wallin A: Cognitive profiles of incipient dementia in the Goteborg MCI study. Dement Geriatr Cogn Disord 2010; 30: 403-410.
41. Hughes TF, Snitz BE, Ganguli M: Should mild cognitive impairment be subtyped? Curr Opin Psychiatry 2011; 24: 237-242.
42. Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ: Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 2010; 9: 119-128.
43. Wagner M, Wolf S, Reischies FM, Daerr M, Wolfsgruber S, Jessen F, Popp J, Maier W, Hüll M, Frölich L, Hampel H, Perneczky R, Peters O, Jahn H, Luckhaus C, Gertz H-J, Schröder J, Pantel J, Lewczuk P, Kornhuber J, Wiltfang J: Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease. Neurology 2012; 78: 379-386.
44. Sarazin M, Chauviré V, Gerardin E, Colliot O, Kinkingnéhun S, de Souza LC, Hugonot-Diener L, Garnero L, Lehéricy S, Chupin M, Dubois B: The amnestic syndrome of hippocampal type in Alzheimer's disease: an MRI study. J Alzheimers Dis 2010; 22: 285-294.
45. Stephan B, Savva G, Brayne C, Bond J, McKeith IG, Matthews FE: Optimizing mild cognitive impairment for discriminating dementia risk in the general older population. Am J Geriatr Psychiatry 2010; 18: 662-673.
46. Gomar JJ, Bobes-Bascaran MT, Conejero-Goldberg C, Davies P, Goldberg TE: Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's Disease Neuroimaging Initiative. Arch Gen Psychiatry 2011; 68: 961-969.
47. Vemuri P, Wiste HJ, Weigand SD, Shaw LM, Trojanowski JQ, Weiner MW, Knopman DS, Petersen RC, Jack CR: MRI and CSF biomarkers in normal, MCI, and AD subjects. Predicting future clinical change. Neurology 2009; 73: 294-301.